Victory Capital Management Inc Durect Corp Transaction History

Victory Capital Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$0.43 - $5.9 $522 - $7,162	-1,214 Reduced 4.57%	25,343 $15,000
Q2 2022 Aug 01, 2022	SELL	$0.38 - $0.64 $57 - $96	-150 Reduced 0.56%	26,557 $13,000
Q1 2022 May 04, 2022	SELL	$0.55 - $0.98 $419 - $746	-762 Reduced 2.77%	26,707 $12,000
Q4 2021 Feb 07, 2022	SELL	$0.9 - $1.31 $768 - $1,118	-854 Reduced 3.02%	27,469 $27,000
Q3 2021 Nov 02, 2021	SELL	$1.21 - $1.61 $1,283 - $1,708	-1,061 Reduced 3.61%	28,323 $36,000
Q2 2021 Aug 03, 2021	SELL	$1.6 - $2.02 $1,414 - $1,785	-884 Reduced 2.92%	29,384 $48,000
Q1 2021 May 04, 2021	BUY	$1.86 - $2.87 $5,018 - $7,743	2,698 Added 9.79%	30,268 $60,000
Q4 2020 Feb 01, 2021	BUY	$1.65 - $2.43 $2,874 - $4,233	1,742 Added 6.74%	27,570 $57,000
Q3 2020 Nov 09, 2020	SELL	$1.6 - $2.35 $4,027 - $5,914	-2,517 Reduced 8.88%	25,828 $44,000
Q2 2020 Aug 07, 2020	SELL	$1.33 - $2.76 $414 - $861	-312 Reduced 1.09%	28,345 $66,000
Q1 2020 May 04, 2020	SELL	$0.97 - $2.85 $629 - $1,849	-649 Reduced 2.21%	28,657 $44,000
Q4 2019 Feb 04, 2020	SELL	$1.69 - $3.8 $5,801 - $13,045	-3,433 Reduced 10.49%	29,306 $56,000
Q3 2019 Nov 12, 2019	BUY	$0.61 - $2.21 $19,970 - $72,353	32,739 New	32,739 $60,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.